Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 11:07 a.m.

    🏢 Jounce Therapeutics Inc (the company became a subdivision of the company Concentra (Frankfurt: DI7U.F)) (JNCE) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-04
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-30.55M $-70.88M $40.33M +56.90% 📉
    Total Assets $252.70M $188.90M $63.80M +33.77% 📈
    Total Liabilities $28.89M $31.17M $-2.28M -7.31% 📈
    Stockholders' Equity $278.46M $-181.55M $460.01M +253.38% 📈
    Operating Income/Loss $-30.63M $-71.18M $40.54M +56.96% 📉
    R&D Expense $42.61M $56.32M $-13.71M -24.35% 📈
    Earningspersharebasic $-0.63 $-1.37 $0.74 +54.01% 📈
    Earningspersharediluted $-0.63 $-1.37 $0.74 +54.01% 📈
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories